<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.fiercebioresearcher.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Cancer</title>
 <link>http://www.fiercebioresearcher.com/tags/cancers</link>
 <description></description>
 <language>en</language>
<item>
 <title>Two pioneers first women to get top research prize</title>
 <link>http://www.fiercebioresearcher.com/story/two-pioneers-first-women-to-get-top-research-prize/2008-05-06?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FBR0</link>
 <description> Two doctors engaged in RNA research--Dr. Joan Steitz, Ph.D., and Dr. Elizabeth Blackburn, Ph.D.--became the first women to win the prestigious Albany Medical Center Prize, one of the richest awards &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebioresearcher.com/story/two-pioneers-first-women-to-get-top-research-prize/2008-05-06&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercebioresearcher.com/story/two-pioneers-first-women-to-get-top-research-prize/2008-05-06#comments</comments>
 <category domain="http://www.fiercebioresearcher.com/tags/albany-medical-center-prize">Albany Medical Center Prize</category>
 <category domain="http://www.fiercebioresearcher.com/tags/cancers">Cancer</category>
 <category domain="http://www.fiercebioresearcher.com/tags/elizabeth-blackburn">Elizabeth Blackburn</category>
 <category domain="http://www.fiercebioresearcher.com/tags/joan-steitz">Joan Steitz</category>
 <category domain="http://www.fiercebioresearcher.com/tags/messenger-rna">messenger rna</category>
 <pubDate>Tue, 06 May 2008 06:59:59 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">7854 at http://www.fiercebioresearcher.com</guid>
</item>
<item>
 <title>Researchers flag new cancer therapy that guards p53</title>
 <link>http://www.fiercebioresearcher.com/story/researchers-flag-new-cancer-therapy-that-guards-p53/2008-05-06?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FBR0</link>
 <description>Scientists in Scotland say that they have identified a chemical group that can protect the p53 gene, a guardian against cancer tumors which is damaged or turned off in most cancer cases. They believe &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebioresearcher.com/story/researchers-flag-new-cancer-therapy-that-guards-p53/2008-05-06&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercebioresearcher.com/story/researchers-flag-new-cancer-therapy-that-guards-p53/2008-05-06#comments</comments>
 <category domain="http://www.fiercebioresearcher.com/tags/cancers">Cancer</category>
 <category domain="http://www.fiercebioresearcher.com/channel/cell-biology">Cell Biology</category>
 <category domain="http://www.fiercebioresearcher.com/tags/enzymes">Enzymes</category>
 <category domain="http://www.fiercebioresearcher.com/tags/guardian">guardian</category>
 <category domain="http://www.fiercebioresearcher.com/tags/tumor">tumors</category>
 <pubDate>Tue, 06 May 2008 06:59:59 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">7857 at http://www.fiercebioresearcher.com</guid>
</item>
<item>
 <title>ALSO NOTED:  StemCyte to open NJ facility; Cornell researchers win million-dollar grant;</title>
 <link>http://www.fiercebioresearcher.com/story/also-noted-stemcyte-to-open-nj-facility-cornell-researchers-win-million-dol/2008-05-06?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FBR0</link>
 <description>Stem Cell Research California&#039;s StemCyte will open a facility in New Jersey and hire 12 people to do stem cell research work. The company was drawn to the state with $589,000 in state grants. &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebioresearcher.com/story/also-noted-stemcyte-to-open-nj-facility-cornell-researchers-win-million-dol/2008-05-06&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercebioresearcher.com/story/also-noted-stemcyte-to-open-nj-facility-cornell-researchers-win-million-dol/2008-05-06#comments</comments>
 <category domain="http://www.fiercebioresearcher.com/tags/cancers">Cancer</category>
 <category domain="http://www.fiercebioresearcher.com/tags/shinya-yamanaka">Shinya Yamanaka</category>
 <category domain="http://www.fiercebioresearcher.com/tags/skin-cells">skin cells</category>
 <category domain="http://www.fiercebioresearcher.com/tags/stem-cell">Stem Cells</category>
 <pubDate>Tue, 06 May 2008 06:59:58 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">7853 at http://www.fiercebioresearcher.com</guid>
</item>
<item>
 <title>Group launches $1B program to study cancer triggers</title>
 <link>http://www.fiercebioresearcher.com/story/group-launches-1b-program-to-study-cancer-triggers/2008-04-29?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FBR0</link>
 <description> An international consortium of researchers has launched a billion-dollar effort to map every way that changes in DNA contributes to the development of tumors. The newly launched International Cancer &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebioresearcher.com/story/group-launches-1b-program-to-study-cancer-triggers/2008-04-29&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercebioresearcher.com/story/group-launches-1b-program-to-study-cancer-triggers/2008-04-29#comments</comments>
 <category domain="http://www.fiercebioresearcher.com/tags/cancers">Cancer</category>
 <pubDate>Tue, 29 Apr 2008 06:59:59 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">7848 at http://www.fiercebioresearcher.com</guid>
</item>
<item>
 <title>ALSO NOTED:  Genetic mutation explains beta blocker failure; CytImmune lauded for nanotech research;New adult stem cell center;</title>
 <link>http://www.fiercebioresearcher.com/story/also-noted-genetic-mutation-explains-beta-blocker-failure-cytimmune-lauded-/2008-04-29?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FBR0</link>
 <description>Research Technology An article in the Journal of Alzheimer&#039;s Disease presents a detailed characterization of a new drug discovery tool for Alzheimer&#039;s disease. It demonstrates that an abnormal form &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebioresearcher.com/story/also-noted-genetic-mutation-explains-beta-blocker-failure-cytimmune-lauded-/2008-04-29&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercebioresearcher.com/story/also-noted-genetic-mutation-explains-beta-blocker-failure-cytimmune-lauded-/2008-04-29#comments</comments>
 <category domain="http://www.fiercebioresearcher.com/tags/cancers">Cancer</category>
 <category domain="http://www.fiercebioresearcher.com/tags/decode-genetics-0">Decode Genetics</category>
 <category domain="http://www.fiercebioresearcher.com/tags/gene-mutation">genetics</category>
 <category domain="http://www.fiercebioresearcher.com/tags/korean-researchers">korean researchers</category>
 <category domain="http://www.fiercebioresearcher.com/tags/tumor">tumors</category>
 <pubDate>Tue, 29 Apr 2008 06:59:58 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">7847 at http://www.fiercebioresearcher.com</guid>
</item>
<item>
 <title>Merck KGaA budgets $1.58B for drug R&amp;D</title>
 <link>http://www.fiercebioresearcher.com/story/merck-kgaa-budgets-1.58b-for-drug-rd/2008-04-22?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FBR0</link>
 <description>With about 40 drug development projects in the pipeline, Germany&#039;s Merck KGaA says it will spend about &amp;#8364;1 billion ($1.58 billion) on drug research this year. That R&amp;amp;D budget represents &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebioresearcher.com/story/merck-kgaa-budgets-1.58b-for-drug-rd/2008-04-22&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercebioresearcher.com/story/merck-kgaa-budgets-1.58b-for-drug-rd/2008-04-22#comments</comments>
 <category domain="http://www.fiercebioresearcher.com/tags/cancers">Cancer</category>
 <category domain="http://www.fiercebioresearcher.com/tags/diabetics">Diabetes</category>
 <category domain="http://www.fiercebioresearcher.com/tags/merck-0">Merck</category>
 <pubDate>Tue, 22 Apr 2008 06:59:59 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">7842 at http://www.fiercebioresearcher.com</guid>
</item>
<item>
 <title>Nanoparticle program delivers anti-cancer therapy</title>
 <link>http://www.fiercebioresearcher.com/story/nanoparticle-program-delivers-anti-cancer-therapy/2008-04-15?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FBR0</link>
 <description> A research team at Washington University in St. Louis has combined a nanoparticle platform used in imaging growing blood vessels and combined it with the fungal drug fumagillin to create a new &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebioresearcher.com/story/nanoparticle-program-delivers-anti-cancer-therapy/2008-04-15&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercebioresearcher.com/story/nanoparticle-program-delivers-anti-cancer-therapy/2008-04-15#comments</comments>
 <category domain="http://www.fiercebioresearcher.com/tags/blood-vessels">blood vessels</category>
 <category domain="http://www.fiercebioresearcher.com/tags/cancers">Cancer</category>
 <category domain="http://www.fiercebioresearcher.com/tags/fumagillin">fumagillin</category>
 <category domain="http://www.fiercebioresearcher.com/tags/joseph-desimone">Joseph DeSimone</category>
 <category domain="http://www.fiercebioresearcher.com/tags/nanotechnology">nanotechnology</category>
 <pubDate>Tue, 15 Apr 2008 06:59:59 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">7838 at http://www.fiercebioresearcher.com</guid>
</item>
<item>
 <title>Two therapeutic targets identified for metastasis</title>
 <link>http://www.fiercebioresearcher.com/story/two-therapeutic-targets-identified-for-metastasis/2008-04-08?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FBR0</link>
 <description> Scientists at Memorial Sloan-Kettering Cancer Center in New York City have identified the molecular process by which breast cancer cells spread to other tissue during metastasis. A signaling &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebioresearcher.com/story/two-therapeutic-targets-identified-for-metastasis/2008-04-08&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercebioresearcher.com/story/two-therapeutic-targets-identified-for-metastasis/2008-04-08#comments</comments>
 <category domain="http://www.fiercebioresearcher.com/tags/breast-cancer-risk">breast cancer</category>
 <category domain="http://www.fiercebioresearcher.com/tags/cancers">Cancer</category>
 <category domain="http://www.fiercebioresearcher.com/tags/karl-saxe">Karl Saxe</category>
 <category domain="http://www.fiercebioresearcher.com/tags/molecule">molecules</category>
 <category domain="http://www.fiercebioresearcher.com/tags/tgf-beta">TGF-beta</category>
 <pubDate>Tue, 08 Apr 2008 06:59:59 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">7830 at http://www.fiercebioresearcher.com</guid>
</item>
<item>
 <title>Researcher nabs $1M Gotham Prize for cancer idea</title>
 <link>http://www.fiercebioresearcher.com/story/researcher-nabs-1m-gotham-prize-for-cancer-idea/2008-04-01?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FBR0</link>
 <description>A professor at the California Institute of Technology is walking away with the $1 million &lt;A &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebioresearcher.com/story/researcher-nabs-1m-gotham-prize-for-cancer-idea/2008-04-01&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercebioresearcher.com/story/researcher-nabs-1m-gotham-prize-for-cancer-idea/2008-04-01#comments</comments>
 <category domain="http://www.fiercebioresearcher.com/tags/cancers">Cancer</category>
 <category domain="http://www.fiercebioresearcher.com/tags/harvard-university">Harvard Medical School</category>
 <category domain="http://www.fiercebioresearcher.com/tags/lasker-prize">Lasker Prize</category>
 <category domain="http://www.fiercebioresearcher.com/tags/national-institutes-health">National Institutes of Health</category>
 <category domain="http://www.fiercebioresearcher.com/tags/research-groups">research groups</category>
 <pubDate>Tue, 01 Apr 2008 07:59:59 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">7827 at http://www.fiercebioresearcher.com</guid>
</item>
<item>
 <title>FDA&#039;s Pazdur in the middle of intense debate</title>
 <link>http://www.fiercebioresearcher.com/story/fda-s-pazdur-in-the-middle-of-intense-debate/2008-03-18?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FBR0</link>
 <description> The argument over the FDA&#039;s role in regulating cancer therapies often comes down to one man: Dr. Richard Pazdur, a veteran oncologist and chief of the agency&#039;s oncology office. Patient groups and &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebioresearcher.com/story/fda-s-pazdur-in-the-middle-of-intense-debate/2008-03-18&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercebioresearcher.com/story/fda-s-pazdur-in-the-middle-of-intense-debate/2008-03-18#comments</comments>
 <category domain="http://www.fiercebioresearcher.com/tags/cancers">Cancer</category>
 <category domain="http://www.fiercebioresearcher.com/tags/cancer-drugs">Cancer Drugs</category>
 <category domain="http://www.fiercebioresearcher.com/tags/fda">FDA</category>
 <category domain="http://www.fiercebioresearcher.com/tags/lawmakers">Regulators</category>
 <category domain="http://www.fiercebioresearcher.com/tags/richard-pazdur">Richard Pazdur</category>
 <pubDate>Tue, 18 Mar 2008 07:59:59 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">7814 at http://www.fiercebioresearcher.com</guid>
</item>
</channel>
</rss>
